Advertisement

Topics

Endocrinology Reports

12:41 EDT 27th July 2017 | BioPortfolio

Male Hypogonadism Market by Therapy Testosterone Replacement therapy and Gonadotropin and GonadotropinReleasing Hormones Therapy Luteinizing Hormone LH, FollicleStimulating Hormone FSH, Human Chorionic Gonadotropin hCG, and GonadotropinReleasing Hormone G

Male hypogonadism is a medical condition characterized by the inability of the testes to produce sufficient amount of testosterone, which is responsible for the development of secondary sexual characteristics. This results in underdevelopment of muscles, impaired growth of body hair, development of breast tissues, and lack of deepening of the voice.nnThe global male hypogonadism market was valued ...

Global Human Growth Hormone Market Research 2011 2022 [Report Updated: 21042017] Prices from USD $2080

SummaryThe global Human Growth Hormone market is estimated to reach 3.6 Billion USD in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report describes major products type ...

Sleep Aids Market by Product Mattress Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices and Sleep Disorder Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking, and Other Sleep Disorders Global Opportunity Analysis and

Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia. Sleep disorders are caused due to substance misuse, stressful work environment, and inconsistent sleep pattern. Sleep aids help to improve the quality of sleep by reducing the time required to fall asleep and increasing the duration of quality sleep. The global sleep aids market ...

Hormone Replacement Therapy HRTGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Hormone Replacement Therapy HRTGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hormone Replacement Therapy HRT Report is to understand the market and pipeline status of the drugs around the...

Hormone Refractory Breast CancerGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Hormone Refractory Breast CancerGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hormone Refractory Breast Cancer Report is to understand the market and pipeline status of the drugs around t...

Metastatic Hormone Refractory Castration Resistant, AndrogenIndependent Prostate CancerGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Metastatic Hormone Refractory Castration Resistant, AndrogenIndependent Prostate CancerGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Metastatic Hormone Refractory Castration Resistant, An...

GonadotropinReleasing Hormone GnRH Receptor LHRH Receptor Antagonists Pipeline Insights, 2017 [Report Updated: 30052017] Prices from USD $1063

DelveInsight's, GonadotropinReleasing Hormone GnRH Receptor LHRH Receptor AntagonistsPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the GonadotropinReleasing Hormone GnRH Receptor LHRH Receptor Antagonists. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Preclinical...

Growth Hormone Antagonists Pipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Growth Hormone AntagonistsPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Antagonists. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product cli...

Hearing DisordersPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Hearing DisordersPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Hearing Disorders. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials info...

Menopausal DisordersPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Menopausal DisordersPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Menopausal Disorders. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trial...

Metastatic Hormone Refractory Prostate CancerPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Metastatic Hormone Refractory Prostate CancerPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Hormone Refractory Prostate Cancer. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregi...

Hormone Replacement Therapy HRTGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Hormone Replacement Therapy HRTGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hormone Replacement Therapy HRT Report is to understand the market and pipeline status of the drugs around the...

Hormone Refractory Breast CancerPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Hormone Refractory Breast CancerPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Hormone Refractory Breast Cancer. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers th...

Muscle Wasting DisordersPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Muscle Wasting DisordersPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Muscle Wasting Disorders. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinic...

Growth Hormone DeficiencyGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Growth Hormone DeficiencyGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Growth Hormone Deficiency Report is to understand the market and pipeline status of the drugs around the Growth Horm...

Appetite Eating DisordersPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Appetite Eating DisordersPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Appetite Eating Disorders. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clin...

Growth Hormone DeficiencyPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Growth Hormone DeficiencyPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Deficiency. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clin...

Adrenal InsufficiencyGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Adrenal InsufficiencyGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Adrenal Insufficiency Report is to understand the market and pipeline status of the drugs around the Adrenal Insufficien...

Growth Hormone GH Agonists Pipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Growth Hormone GH AgonistsPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone GH Agonists. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product cli...

Cognitive DisordersPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Cognitive DisordersPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Cognitive Disorders. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials ...

Movement DisordersPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Movement DisordersPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Movement Disorders. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials in...

Adrenocortical Carcinoma Adrenal Cortex CancerPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Adrenocortical Carcinoma Adrenal Cortex CancerPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Adrenocortical Carcinoma Adrenal Cortex Cancer. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Prere...

Myeloproliferative DisordersPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Myeloproliferative DisordersPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Myeloproliferative Disorders. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the produc...

Parathyroid Hormone Receptor Agonist Pipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Parathyroid Hormone Receptor AgonistPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Parathyroid Hormone Receptor Agonist. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report co...

GonadotropinReleasing Hormone GnRH Receptor LHRH Receptor Antagonists Pipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, GonadotropinReleasing Hormone GnRH Receptor LHRH Receptor AntagonistsPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the GonadotropinReleasing Hormone GnRH Receptor LHRH Receptor Antagonists. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Preclinical...

Quick Search
Advertisement
 

review and buy Endocrinology market research data and corporate reports here